← SynDRA
REPAGLINIDE
SynDRA canonical compound SYN0004980 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ABCC8 |
|---|
| Mechanism of action | Insulin secretagogue |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
- ABCC8
- KCNJ11
- ABCC9
- CYP2C8
- CYP3A5
- INS
- PPARG
- SLC22A1
- SLCO1B1
Mechanisms of action (all sources)
- Insulin secretagogue
- KCNJ11 BLOCKER
- Sulfonylurea receptor 1, Kir6.2 blocker
- ABCC8 BLOCKER
- ABCC9 BLOCKER
Drug classes
- Glinide
- Potassium Channel Antagonists
- Hypoglycemic Agents
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- (S)-(+)-Repaglinide
- prandin
- enyglid
- surepost
- REPAGLINIDA
- A10BX02
- AG-EE 388 ZW
- AG-EE-623-ZW
- AG-EE-623ZW
- AGEE-623ZW
- CHEMBL1272
- Enyglid
- Novonorm
- NSC-759893
- Prandin
- Repaglinide accord
- Repaglinide component of prandimet
- Repaglinide krka
- Repaglinide teva
- Actulin
- GlucoNorm
- NovoNorm
- Repaglinida
- Repaglinidum
- Glaxo Wellcome brand of replaginide
- Novo Nordisk brand of repaglinide
- Repaglinide [USAN]
- Novo Nordisk brand 2 of repaglinide
- AG-EE-388
- AG-EE-623 ZW
- GlucoNorm (TN)
- NN-623
- NovoNorm (TN)
- Prandin (TN)
- Repa-glinide
- Repaglinida [INN-Spanish]
- Repaglinidum [INN-Latin]
- SMP-508
Reported adverse events
- Nausea
- Vomiting
- Arthralgia
- Chest pain
- Constipation
- Dyspepsia
- Urinary tract infection
- Death
- Sinusitis
- Alopecia
- Pancreatitis
- Bronchitis
Look up REPAGLINIDE in the interactive SynDRA portal →